Marisa Martino · New York
Skinney MedSpa
Disclosed relationships: manufacturer employee or representative.
Muscle & Fat · HIFEM + RF
Technology: EMS & Muscle Stimulation
Data on file
Figures are reference points, not current offers. Used asking prices are not completed-sale values.
Latest price source dated: Aug 12, 2026 · Manufacturer-source documents checked: August 31, 2026
·FDA database · Updated Aug 12, 20261 of 1 reviewers would buy again
K192224 (Btl, 2019)
BTL-899 is indicated to be used for: • Non-invasive lipolysis (breakdown of fat) of the abdomen. • Reduction in circumference of the abdomen • The BTL-899 is intended for use with Skin Type I to Skin Type III.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K202199 (Btl, 2021)
BTL-899ST is indicated to be used for: • Non-invasive lipolysis (breakdown of fat) of the abdomen. • Reduction in circumference of the abdomen. • Non-invasive lipolysis (breakdown of fat) of the thighs. • Reduction in circumference of the thighs. • BTL-899ST is intended for use with Skin Type I, II and III.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Page updated: September 22, 2026 · How we verify
Axis runs $0–$300k. Reference figures, not current offers. Used asking prices are not completed-sale values.
Not verified
We hold no per-treatment consumable price for this device from a dated source. Ask the seller for a written per-treatment cost.
| Manufacturer | BTL Aesthetics |
|---|---|
| Company | Owner: BTL Group; founder-controlled (private) (family / founder owned, since 1993) · Distribution: direct |
| Parent company | BTL Aesthetics |
| Brand owner | BTL Aesthetics |
| Built by (OEM) | BTL Industries |
| Category | Body Contouring |
| Technology | HIFEM + RF |
| FDA status | FDA Cleared |
| 510(k) citation | K192224, K202199 |
| New price range | $250k–$300k (estimate) |
| Used asking range | $90k–$160k |
| Consumables | No per-treatment cycle card, gel, or disposable tip. Recurring spend is patient belts and paddle replacement when the paddle minutes counter ends (a capital cost). |
| Launch year | 2020 |
| Latest price source dated | Aug 12, 2026 |
| Manufacturer-source documents checked | August 31, 2026 |
Other devices to research: CoolTone, truFlex, CMSlim and physiq. Check each model’s intended treatments and evidence.
For a pre-owned unit, confirm applicator condition, remaining usage and warranty transfer terms.
How the technology works
Simultaneous HIFEM muscle stimulation and synchronized RF fat heating in one applicator: RF raises subcutaneous fat to apoptosis-inducing temperatures while HIFEM drives ~20,000+ supramaximal contractions per 30-minute session.
BTL's cited clinical series show ~25-30% average fat reduction and ~25% muscle increase in treated areas over a 4-session course — best-documented combined effect in the category. Cleared for abdomen and thighs lipolysis/circumference plus muscle strengthening/toning across multiple body areas.
Patented technology
HIFEM with synchronized RF delivered from a single applicator; BTL states the combination is patented.
Origin
Czech Republic (BTL Industries; US subsidiary Marlborough, MA).
FDA-cleared indications (verbatim)
K192224 (Btl, 2019)
BTL-899 is indicated to be used for: • Non-invasive lipolysis (breakdown of fat) of the abdomen. • Reduction in circumference of the abdomen • The BTL-899 is intended for use with Skin Type I to Skin Type III.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
K202199 (Btl, 2021)
BTL-899ST is indicated to be used for: • Non-invasive lipolysis (breakdown of fat) of the abdomen. • Reduction in circumference of the abdomen. • Non-invasive lipolysis (breakdown of fat) of the thighs. • Reduction in circumference of the thighs. • BTL-899ST is intended for use with Skin Type I, II and III.
Verbatim from the FDA 510(k) summary, retrieved 8 Sep 2026.
Marketed for
EMS / muscle stimulation — HIFEM + RF
Marketing claims are the manufacturer's own and are not the same as a cleared indication.
Parent company: BTL Aesthetics
Legal manufacturer: BTL Industries (Bulgaria)
Applicant on the FDA record
BtlThe applicant named on the FDA record can differ from the brand shown on the device.
Clearance notes
K192224 plus follow-ons — cleared for non-invasive lipolysis and circumference reduction of the abdomen (later expanded to thighs and additional applicators), plus HIFEM muscle strengthening/toning clearances.
Regulatory data comes from public FDA records and may lag recent updates. Confirm the applicable status and documentation before purchase.
Comparing an unbranded HIFEM / electromagnetic muscle-stimulation unit? Check the exact model rather than relying on similar photos or treatment claims.
Listed manufacturer for this profile: BTL Industries
We do not profile these unbranded units or verify their support and financing terms. This profile’s FDA record applies to the named device, not every similar-looking unit.
No treatment schedule documented yet.
No sourced treatment price on file.
Model revenue using the price you expect to collect and the sessions you expect to complete. Account for package discounts and staff time.
Ask for written applicator replacement costs, usage limits, service terms and financing details before estimating profit or payback.
No per-treatment cycle card, gel, or disposable tip. Recurring spend is patient belts and paddle replacement when the paddle minutes counter ends (a capital cost).
No annual service cost documented yet.
Pre-filled from our published BTL Aesthetics Emsculpt NEO data where we have it. Estimates appear once the required inputs are available. Review and adjust every pre-filled value before relying on the result.
Start from
No verified per-treatment supply cost is on file. Enter your own allowance. Use $0 only if you have confirmed that it applies to your practice.
Pre-filled from the midpoint of the published new-price range
20 is an illustrative default — change it to your volume.
No sourced per-session price on file — enter what you charge.
Required — enter your cost; missing data does not mean $0.
Provider or tech time for one treatment, fully loaded. Enter 0 if you own-operate.
Annual service contract ÷ 12, if you carry one.
Enter price you charge per treatment, consumable cost per treatment to see contribution and a payback range.
This model ignores financing — if you lease or borrow, add your monthly payment. Estimates from your inputs and our published ranges — not a projection, guarantee or financial advice. How we calculate this.
Contraindications & screening
Implanted electronic devices, metal implants including copper IUDs in the field, pregnancy, hernias in the treatment area, recent surgery, seizure history.
Before buying new or used, confirm in writing:
A chain listing does not establish availability at every location.
Ever/Body
Cosmetic dermatology
Chain treatment menu
VIO Med Spa
Medspa franchise
Chain treatment menu / vendor partner list
Schweiger Dermatology Group
PE-backed dermatology roll-up
Practice service pages
Device user rating 5.0 · 1 reviewSmall sample: fewer than 10 scored reviews.
1 response
1 response
1 response
1 response
1 response
1 response
1 owner or operator review. Overall satisfaction is scored separately from the categories.
Purchase price, treatment volume and payback medians appear after 20 owner responses with economic data. Methodology.
Marisa Martino · New York
Skinney MedSpa
Disclosed relationships: manufacturer employee or representative.
Current catalog models to research. Confirm availability and configuration with the supplier.
Includes current and older models.
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
September 22, 2026
New price range
$250k–$300k list (negotiated deals commonly below) → $250k–$300k (estimate)
Source: Catalog update
September 22, 2026
New price range
$250k–$300k list (negotiated deals commonly below) → $250k–$300k (estimate)
Removed unsupported negotiation/discount advice from buyer-facing catalog copy. Emsculpt NEO range relabeled as an estimate; no new pricing observation or verification. Original text retained in this history.
Source: Catalog update
September 19, 2026
Economics and overview evidence
Replaced unsupported treatment-price, margin or comparative assertions in economics and overview prose with neutral quote-planning guidance. No purchase prices, source records, review scores, model status or verification dates changed. Full earlier wording is retained in this database correction record; the public history shows this summary.
Source: Catalog update
September 8, 2026
notes
Catalog update — superlatives, margin judgements and unsourced dollar claims removed (neutral-voice standard, 8 Sep 2026)
Source: Editorial standard
September 7, 2026
notes
Source: Catalog update — editorial sentences removed (neutral-voice standard, 7 Sep 2026)
September 7, 2026
patented tech
Source: Catalog update — editorial sentences removed (neutral-voice standard, 7 Sep 2026)
September 4, 2026
patented tech
Manufacturer-conduct language removed or restated as a dated, sourced fact.
Source: Editorial sweep 2026-09-04: manufacturer-conduct language neutralized
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Cite this data: The Aesthetic Index, "BTL Aesthetics Emsculpt NEO — pricing, FDA status and cost to own", aestheticindex.co (accessed September 24, 2026).
Get the full State of Aesthetic Devices 2026 report
A catalog of US-marketed aesthetic and wellness devices — preview it free.
Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.